-

Novālent Launches Patented US Technology in Australia & New Zealand Markets to Help Fight COVID-19

GREENSBORO, N.C.--(BUSINESS WIRE)--Novālent Biotech, Inc (‘Novālent’), a US biotechnology engineering firm, announces it is launching its patented surface disinfectant products in Australia and New Zealand.

Novālent technology protects against bacteria and viruses on surfaces for up to 90 days. The antimicrobial is applied to surfaces by wiping, spraying, or fogging. Once dry, the surface remains protected even if touched or recontaminated multiple times.

Even routine disinfecting does not diminish Novālent’s protective properties. The technology is based on a patented non-toxic monomolecular layer that provides up to 90 days of antimicrobial protection. Novālent products have applications across industries including buildings and facilities, food service, hospitality, fitness, healthcare, transport, and textiles and apparel.

“We’ve seen a rapid adoption of our technology in the US from market leaders including PepsiCo, Hanesbrands, and Pilgrim’s,” said Kevin Parrish, CEO of Novālent. “We are now bringing this technology to the Australia and New Zealand market to provide customers with a truly revolutionary product based on more than two decades of research by our R&D engineering team in the US.”

The Australian Therapeutic Goods Administration (TGA) has registered Novālent technology as an effective commercial-grade surface disinfectant against coronaviruses including the virus that causes COVID-19.

About Novālent

Novālent® is a leading U.S. biotechnology engineering firm which has pioneered the development of proprietary, long-lasting technology that protects against germs. Novālent® technology is based on a patented, non-toxic monomolecular layer that continuously inhibits the growth of bacteria for up to 90 days on surfaces. Used by leading US firms including PepsiCo, Pilgrims and HanesBrands, Novālent is private equity-backed and is headquartered in Greensboro, North Carolina, with five offices around the world. Visit www.novalent.com for more information.

Contacts

Christine Pietryla Wetzler
christine@pietrylapr.com

Industry:

Novālent Biotech, Inc

Release Versions
English

Contacts

Christine Pietryla Wetzler
christine@pietrylapr.com

More News From Novālent Biotech, Inc

Novālent is Now Available at Walmart Inc.

GREENSBORO, N.C.--(BUSINESS WIRE)--Novālent Biotech, Inc (‘Novālent’), a U.S. biotechnology engineering firm, is pleased to announce that after a nine-month review Novālent long lasting surface protection technology is available at Walmart stores in the United States. “Walmart is an important distribution partner given its unparallel scale and reach,” said Kevin Parrish, Novālent CEO. “By having our technology available readily throughout the US now means clients of all sizes can benefit from N...

Novālent Partners with Birko Corporation

GREENSBORO, N.C.--(BUSINESS WIRE)--Novālent Biotech, Inc (‘Novālent’), a U.S. biotechnology engineering firm, is partnering with Birko, a leader in providing integrated sanitation solutions in the brewing and distilling, produce, meat, poultry and protein industries. This partnership pairs two trusted brands to offer best-in-class residual antimicrobial solutions to food and beverage companies in North America. Novālent coating technology is for use as a residual antimicrobial under EPA and FDA...

Novālent is HACCP Certified

GREENSBORO, N.C.--(BUSINESS WIRE)--Novālent Biotech, Inc (‘Novālent’), a U.S. biotechnology engineering firm, is pleased to share its facilities are Hazard Analysis Critical Control Point (HACCP) certified. “Earning the GMP/HACCP certification in our manufacturing plant is a competitive advantage. This is a big deal when it comes to adding another layer of food safety for our food and beverage customers. In today’s world where there is a heightened awareness for food protection, this certificat...
Back to Newsroom